ARTICLE | Company News
Boehringer Ingelheim invests €230M in new biologics center
June 29, 2018 9:18 PM UTC
Boehringer Ingelheim GmbH (Ingelheim, Germany) will invest €230 million ($268 million) in a new biologicals development center at its R&D site in Biberach, Germany...
BCIQ Company Profiles